ATIM-49 (LTBK-01). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE®) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM)
Rosenthal, Mark A, Balana, Carmen, van Linde, Myra E, Sayehli, Cyrus, Fiedler, Walter M, Wermke, Martin, Massard, Christophe, Mellinghoff, Ingo K, Khasraw, Mustafa, Ang, Agnes, Rasmussen, Erik, Kast,Volume:
21
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz219.1195
Date:
November, 2019
File:
PDF, 105 KB
2019